122 related articles for article (PubMed ID: 32306138)
1. Age-Dependent Progression in Lung Pathophysiology can be Prevented by Restoring Fatty Acid and Ceramide Imbalance in Cystic Fibrosis.
Youssef M; De Sanctis JB; Shah J; Dumut DC; Hajduch M; Petrof BJ; Radzioch D
Lung; 2020 Jun; 198(3):459-469. PubMed ID: 32306138
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Allergic Asthma with Fenretinide Formulation (LAU-7b) Downregulates ORMDL Sphingolipid Biosynthesis Regulator 3 (
Youssef M; De Sanctis JB; Shah J; Dumut DC; Hajduch M; Naumova AK; Radzioch D
J Pharmacol Exp Ther; 2020 Jun; 373(3):476-487. PubMed ID: 32273303
[TBL] [Abstract][Full Text] [Related]
3. Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside.
Garić D; De Sanctis JB; Wojewodka G; Houle D; Cupri S; Abu-Arish A; Hanrahan JW; Hajduch M; Matouk E; Radzioch D
J Mol Med (Berl); 2017 Oct; 95(10):1053-1064. PubMed ID: 28695226
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Optimized Treatment Protocol Using LAU-7b Formulation against Ovalbumin (OVA) and House Dust Mite (HDM) -Induced Allergic Asthma in Atopic Hyperresponsive A/J Mice.
Youssef M; De Sanctis JB; Kanagaratham C; Tao S; Ahmed E; Radzioch D
Pharm Res; 2020 Jan; 37(2):31. PubMed ID: 31915990
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide.
Guilbault C; Wojewodka G; Saeed Z; Hajduch M; Matouk E; De Sanctis JB; Radzioch D
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):100-6. PubMed ID: 19059886
[TBL] [Abstract][Full Text] [Related]
6. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.
Guilbault C; De Sanctis JB; Wojewodka G; Saeed Z; Lachance C; Skinner TA; Vilela RM; Kubow S; Lands LC; Hajduch M; Matouk E; Radzioch D
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):47-56. PubMed ID: 17656682
[TBL] [Abstract][Full Text] [Related]
7. Treatment With LAU-7b Complements CFTR Modulator Therapy by Improving Lung Physiology and Normalizing Lipid Imbalance Associated With CF Lung Disease.
Centorame A; Dumut DC; Youssef M; Ondra M; Kianicka I; Shah J; Paun RA; Ozdian T; Hanrahan JW; Gusev E; Petrof B; Hajduch M; Pislariu R; De Sanctis JB; Radzioch D
Front Pharmacol; 2022; 13():876842. PubMed ID: 35668939
[TBL] [Abstract][Full Text] [Related]
8. Partial Restoration of CFTR Function in cftr-Null Mice following Targeted Cell Replacement Therapy.
Duchesneau P; Besla R; Derouet MF; Guo L; Karoubi G; Silberberg A; Wong AP; Waddell TK
Mol Ther; 2017 Mar; 25(3):654-665. PubMed ID: 28187947
[TBL] [Abstract][Full Text] [Related]
9. Goblet cell hyperplasia is not epithelial-autonomous in the Cftr knockout intestine.
Walker NM; Liu J; Young SM; Woode RA; Clarke LL
Am J Physiol Gastrointest Liver Physiol; 2022 Feb; 322(2):G282-G293. PubMed ID: 34878935
[TBL] [Abstract][Full Text] [Related]
10. CFTR Correctors and Antioxidants Partially Normalize Lipid Imbalance but not Abnormal Basal Inflammatory Cytokine Profile in CF Bronchial Epithelial Cells.
Veltman M; De Sanctis JB; Stolarczyk M; Klymiuk N; Bähr A; Brouwer RW; Oole E; Shah J; Ozdian T; Liao J; Martini C; Radzioch D; Hanrahan JW; Scholte BJ
Front Physiol; 2021; 12():619442. PubMed ID: 33613309
[TBL] [Abstract][Full Text] [Related]
11. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
Teichgräber V; Ulrich M; Endlich N; Riethmüller J; Wilker B; De Oliveira-Munding CC; van Heeckeren AM; Barr ML; von Kürthy G; Schmid KW; Weller M; Tümmler B; Lang F; Grassme H; Döring G; Gulbins E
Nat Med; 2008 Apr; 14(4):382-91. PubMed ID: 18376404
[TBL] [Abstract][Full Text] [Related]
12. [Cystic fibrosis, fatty acid imbalance, ceramide and lipid rafts].
Chanson M
Arch Pediatr; 2009 Jun; 16(6):543-5. PubMed ID: 19541078
[No Abstract] [Full Text] [Related]
13. Ceramide is increased in the lower airway epithelium of people with advanced cystic fibrosis lung disease.
Brodlie M; McKean MC; Johnson GE; Gray J; Fisher AJ; Corris PA; Lordan JL; Ward C
Am J Respir Crit Care Med; 2010 Aug; 182(3):369-75. PubMed ID: 20395562
[TBL] [Abstract][Full Text] [Related]
14. Fenretinide prevents the development of osteoporosis in Cftr-KO mice.
Saeed Z; Guilbault C; De Sanctis JB; Henri J; Marion D; St-Arnaud R; Radzioch D
J Cyst Fibros; 2008 May; 7(3):222-30. PubMed ID: 17988958
[TBL] [Abstract][Full Text] [Related]
15. Residual cftr expression varies with age in cftr(tm1Hgu) cystic fibrosis mice: impact on morphology and physiology.
Larbig M; Jansen S; Dorsch M; Bernhard W; Bellmann B; Dorin JR; Porteous DJ; Von Der Hardt H; Steinmetz I; Hedrich HJ; Tuemmler B; Tschernig T
Pathobiology; 2002-2003; 70(2):89-97. PubMed ID: 12476034
[TBL] [Abstract][Full Text] [Related]
16. Subacute TGFβ Exposure Drives Airway Hyperresponsiveness in Cystic Fibrosis Mice through the PI3K Pathway.
Kramer EL; Madala SK; Hudock KM; Davidson C; Clancy JP
Am J Respir Cell Mol Biol; 2020 May; 62(5):657-667. PubMed ID: 31922900
[TBL] [Abstract][Full Text] [Related]
17. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis.
Becker KA; Riethmüller J; Lüth A; Döring G; Kleuser B; Gulbins E
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):716-24. PubMed ID: 19635928
[TBL] [Abstract][Full Text] [Related]
18. Lipid metabolism in cystic fibrosis.
Worgall TS
Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):105-9. PubMed ID: 19209467
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice.
Velsor LW; van Heeckeren A; Day BJ
Am J Physiol Lung Cell Mol Physiol; 2001 Jul; 281(1):L31-8. PubMed ID: 11404242
[TBL] [Abstract][Full Text] [Related]
20. Iron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator.
Deschemin JC; Allouche S; Brouillard F; Vaulont S
PLoS One; 2015; 10(12):e0145685. PubMed ID: 26709821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
